GEMIN7 is a core component of the SMN (survival of motor neurons) complex, which functions as an assembly machine for spliceosomal small nuclear ribonucleoproteins (snRNPs)—the building blocks of the spliceosome 1. GEMIN7 adopts a canonical Sm fold structurally similar to Sm proteins, despite lacking sequence homology, and exists as a stable heterodimer with GEMIN6 2. Within the SMN complex, GEMIN7 interacts directly with SMN and GEMIN6, mediating GEMIN6 association with the SMN complex and facilitating recruitment of Sm proteins to the snRNP assembly pathway 13. GEMIN8 bridges GEMIN7 and GEMIN6 to SMN, and disruption of this interaction impairs Sm protein recruitment but not snRNA binding 3. GEMIN7 specifically interacts with SmE and other Sm proteins essential for core snRNP formation 1. In disease contexts, GEMIN7 expression is significantly reduced in oculomotor nucleus motoneurons compared to spinal cord motoneurons in sporadic amyotrophic lateral sclerosis patients 4. Additionally, GEMIN7 has emerged as a prognostic biomarker in bladder cancer, where altered expression correlates with patient survival outcomes 5. A candidate GEMIN7 variant was identified in a Saudi Arabian cohort, suggesting potential disease association 6.